Agilent Licenses Big Bag of Toys to Incyte | GenomeWeb

NEW YORK, July 10 - Agilent said today it will license a host of microarray and gene-expression tools to nascent drug-developer Incyte Genomics.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.